Dangerous Drugs Board(DDB)

Dear eFOI user,

Thank you for your request dated Sept. 2, 2024, made under Executive Order No. 2 (s. 2016) on Freedom of Information in the Executive Branch.

Dear eFOI user,

Thank you for your request dated Aug. 26, 2024, made under Executive Order No. 2 (s. 2016) on Freedom of Information in the Executive Branch.

I am pleased to inform you that your FOI request has been approved. Enclosed herewith, you will find a copy of the information you have requested. Please note that it may include most of the data you require as follows:

2019-2023 by region

FOI-2020to2024 by type of admission and by region

If you are dissatisfied with our response to your FOI request, you have the option to request an internal review. To initiate this process, kindly submit your written appeal for review addressed to Secretary Catalino S. Cy, CEO VI, at [email protected] by type of admission and by region - Rebecca Arambulo - [email protected]. Please provide a detailed explanation of your dissatisfaction with our response within 15 calendar days from the date of receiving this response. We will conduct the review and communicate the outcome within 30 calendar days from the receipt of your review request.

Should you remain unsatisfied with the review outcome, you retain the right to appeal to the Office of the President under Administrative Order No. 22 (s. 2011).

Thank you.

Respectfully,

FOI Officer

Dangerous Drugs Board